Page results
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This page provides information about anaesthesia for children having proton beam therapy.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This Huntington’s disease service page provides information on Advance Care Planning: it gives patients and their loved ones the opportunity to talk about and document their wishes, preferences and priorities as the disease progresses.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
File results
-
FOI/2021/0572 - Dermatological and rheumatological conditions
-
FOI/2021/0577 - Patient brought to A&E paralysed
-
FOI/2021/0591 - Laboratory/ Pathology information system
-
FOI/2021/0593 - Contact centre/ Call centre contract
-
FOI/2021/0601 - Treatment Guidelines with Systemic lupus erythematosus (SLE) / Lupus nephritis (LN)
-
FOI/2021/0616 - Overseas visitors and migrants
-
FOI/2021/0618 - Number of patient admissions to A&E
-
FOI/2021/0626 - Cardiac output monitors and manufacturer associated disposable products
-
FOI/2021/0100 - DNACPR orders issued - March 2019 to January 2021
-
FOI/2021/0091 - Patients admitted with respiratory conditions - SARS-COV-2